MedPath

MINT-TRIMEBUTINE

MINT-TRIMEBUTINE

Approved
DIN Number

02538210

Drug Class

Human

Market Date

Jan 17, 2024

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02538210
AIG Number0115865004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A03AA05 TRIMEBUTINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:32.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRIMEBUTINE MALEATEActive
Strength: 200 MG
Monograph: TRIMEBUTINE MALEATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.